0.860
0.07 (9.01%)
| Penutupan Terdahulu | 0.789 |
| Jumlah Dagangan | 54,789 |
| Harga / Pendapatan (P/E Ke hadapan) | 9.17 |
| Harga / Jualan (P/S) | 12.06 |
| Harga / Buku (P/B) | 2.40 |
| Julat 52 Minggu |
| EPS Cair (TTM) | -0.380 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 10.66% |
| Nisbah Semasa (MRQ) | 0.360 |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -1.26 M |
| Pulangan Atas Aset (ROA TTM) | -22.41% |
| Pulangan Atas Ekuiti (ROE TTM) | -93.64% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Menaik |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Menaik | |
| Stok | Citius Oncology, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | 2.0 |
| Purata | -0.43 |
|
Citius Oncology Inc is a biopharmaceutical company focused on developing and commercializing targeted oncology therapies.The Company centers on achieving a market position by advancing therapies with reduced development and clinical risks, and competitive advantages supported by intellectual property and regulatory exclusivity protection. This includes new formulations of previously approved drugs with substantial existing safety and efficacy data or expanded indications for approved therapies. The company focused on key geographies and stakeholders, majorly on cancer centers and patients. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 86.80% |
| % Dimiliki oleh Institusi | 0.60% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |